Skip to main content
Year archive

Zealand Pharma — 2017 filings

All 142 regulatory filings released by Zealand Pharma (ZEAL) in 2017, sourced directly from the official regulator.

142 Filings
2017 Period
2017 filings (142)
Filing Released Lang
Regulatory Filings 2017
Regulatory Filings
2017-12-21 English
Zealand Pharma boosts collaboration with Beta Bionics to advance development of its dasiglucagon in the iLetTM
Capital/Financing Update
2017-12-21 English
Regulatory Filings 2017
Regulatory Filings
2017-12-07 English
Zealand Pharma initiates the pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes
Regulatory Filings
2017-12-07 English
Director's Dealing 2017
Director's Dealing
2017-12-06 English
Total number of shares and voting rights in Zealand at November 30, 2017
Share Issue/Capital Change
2017-11-30 English
Total number of shares and voting rights in Zealand at November 30, 2017
Share Issue/Capital Change
2017-11-30 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-11-20 English
Zealand increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2017-11-20 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2017-11-13 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2017-11-13 English
Director's Dealing 2017
Director's Dealing
2017-11-13 English
Interim / Quarterly Report 2017
Interim / Quarterly Report 9M 2017
2017-11-08 English
Zealand Pharma: Interim report for the first nine months of 2017
Interim / Quarterly Report 9M 2017
2017-11-08 English
Earnings Release 2017
Earnings Release Q3 2017
2017-11-02 English
Zealand reports royalty revenue for the third quarter of 2017
Earnings Release Q3 2017
2017-11-02 English
Regulatory Filings 2017
Regulatory Filings
2017-10-24 English
U.S. FDA grants orphan drug designation to glepaglutide for the treatment of short bowel syndrome
Regulatory Filings
2017-10-24 English
Total number of shares and voting rights in Zealand at September 30, 2017
Share Issue/Capital Change
2017-09-29 English
Total number of shares and voting rights in Zealand at September 30, 2017
Share Issue/Capital Change
2017-09-29 English
Zealand increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2017-09-22 English
Zealand increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2017-09-22 English
Zealand increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2017-09-01 English
Zealand increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2017-09-01 English
Total number of shares and voting rights in Zealand at August 31, 2017
Share Issue/Capital Change
2017-08-31 English
Total number of shares and voting rights in Zealand at August 31, 2017
Share Issue/Capital Change
2017-08-31 English
Director's Dealing 2017
Director's Dealing
2017-08-25 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-08-25 English
Zealand grants new warrants under employee warrant program
Remuneration Information
2017-08-25 English
Interim / Quarterly Report 2017
Interim / Quarterly Report H1 2017
2017-08-24 English
Interim report for the first half of 2017
Report Publication Announcement H1 2017
2017-08-24 English
Regulatory Filings 2017
Regulatory Filings
2017-08-22 English
Phase 1 trials for two novel treatments of obesity and/or diabetes initiated by Zealand partner Boehringer Ingelheim
Regulatory Filings
2017-08-22 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-08-18 English
Completion of exercise in full of overallotment option of 15%
Share Issue/Capital Change
2017-08-18 English
Capital/Financing Update 2017
Capital/Financing Update
2017-08-15 English
Overallotment option of 15% has been exercised
Share Issue/Capital Change
2017-08-15 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-08-15 English
End of stabilization period
Regulatory Filings
2017-08-15 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-08-14 English
Completion of the initial public offering of American Depositary Shares and registration of capital increase
Share Issue/Capital Change
2017-08-14 English
Godkendelse af prospekt for ZEALAND PHARMA A/S, Aktier, 10.08.2017
Regulatory Filings
2017-08-10 English
Capital/Financing Update 2017
Capital/Financing Update
2017-08-10 English
Zealand Pharma A/S publishes prospectus
Report Publication Announcement
2017-08-10 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-08-10 English
Zealand Pharma A/S publishes a prospectus regarding listing of 4,375,000 new shares on Nasdaq Copenhagen as part of its issue of American Depositary Shares listed on the Nasdaq in the US
Regulatory Filings
2017-08-10 English
Capital/Financing Update 2017
Capital/Financing Update
2017-08-09 English
Zealand Pharma A/S files final prospectus on a Form F-1 registration statement in connection with the initial public offering of American Depositary Shares in the United States
Report Publication Announcement
2017-08-09 English
Capital/Financing Update 2017
Capital/Financing Update
2017-08-09 English
Stabilization period begins
Capital/Financing Update
2017-08-09 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-08-09 English
Zealand Pharma A/S prices its initial public offering of American Depositary Shares on The Nasdaq Global Select Market in the United States
Capital/Financing Update
2017-08-09 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-08-09 English
Capital/Financing Update 2017
Capital/Financing Update
2017-08-01 English
Zealand Pharma A/S commences initial public offering of American Depositary Shares in the United States
Regulatory Filings
2017-08-01 English
AGM Information 2017
AGM Information
2017-07-31 English
Passing of Zealand Pharma A/S Extraordinary General Meeting on 31 July 2017
AGM Information
2017-07-31 English
Earnings Release 2017
Earnings Release Q2 2017
2017-07-31 English
Zealand reports royalty revenue for the second quarter of 2017
Earnings Release Q2 2017
2017-07-31 English
Zealand Pharma A/S convenes an extraordinary general meeting 2017
Proxy Solicitation & Information Statement
2017-07-07 English
Zealand Pharma A/S convenes an extraordinary general meeting 2017
AGM Information
2017-07-07 English
Capital/Financing Update 2017
Capital/Financing Update
2017-07-06 English
Zealand Pharma files registration statement for proposed initial public offering of ADSs in the U.S.
Capital/Financing Update
2017-07-06 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-07-03 English
Total number of shares and voting rights in Zealand at June 30, 2017
Share Issue/Capital Change
2017-07-03 English
Regulatory Filings 2017
Regulatory Filings
2017-07-03 English
Regulatory Filings 2017
Regulatory Filings
2017-06-22 English
Phase 2a trial results support development of dasiglucagon in the iLet pump system for type 1 diabetes
Regulatory Filings
2017-06-22 English
Earnings Release 2017
Earnings Release Q2 2017
2017-06-19 English
Glepaglutide meets primary endpoint in Phase 2 trial in patients with short bowel syndrome
Regulatory Filings
2017-06-19 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-06-15 English
Zealand increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2017-06-15 English
Regulatory Filings 2017
Regulatory Filings
2017-06-12 English
Zealand to regain control of elsiglutide
Regulatory Filings
2017-06-12 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-05-31 English
Total number of shares and voting rights in Zealand at May 31, 2017
Share Issue/Capital Change
2017-05-31 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-05-30 English
Zealand increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2017-05-30 English
Regulatory Filings 2017
Regulatory Filings
2017-05-23 English
Positive Phase 2a results with microdoses of dasiglucagon support use in a dual-hormone artificial pancreas system
Regulatory Filings
2017-05-23 English
CORRECTION: Zealand reports results for the first three months of 2017 (unaudited)
Interim / Quarterly Report Q1 2017
2017-05-17 English
CORRECTION: Zealand reports results for the first three months of 2017 (unaudited)
Interim / Quarterly Report Q1 2017
2017-05-17 English
Zealand reports results for the first three months of 2017 (unaudited)
Earnings Release Q1 2017
2017-05-17 English
Total number of shares and voting rights in Zealand at April 30, 2017
Share Issue/Capital Change
2017-04-30 English
Total number of shares and voting rights in Zealand at April 30, 2017
Share Issue/Capital Change
2017-04-30 English
Major Shareholding Notification 2017
Major Shareholding Notification
2017-04-27 English
Zealand announces information received from its major shareholder Lønmodtagernes Dyrtidsfond (LD)
Major Shareholding Notification
2017-04-27 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-04-18 English
Zealand announces amendments to its Articles of Association following the granting of warrants
Share Issue/Capital Change
2017-04-18 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-04-13 English
Zealand increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2017-04-13 English
Director's Dealing 2017
Director's Dealing
2017-04-07 English
Director's Dealing 2017
Director's Dealing
2017-04-06 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2017-04-06 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2017-04-06 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2017-04-06 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2017-04-06 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2017-04-06 English
Handel med værdipapirer i Zealand Pharma A/S
Director's Dealing
2017-04-06 English
Remuneration Information 2017
Remuneration Information
2017-04-06 English
Zealand grants new warrants under employee warrant program
Share Issue/Capital Change
2017-04-06 English
Director's Dealing 2017
Director's Dealing
2017-04-06 English
Passing of Zealand's Annual General Meeting in 2017
Declaration of Voting Results & Voting Rights Announcements
2017-04-05 English
Passing of Zealand's Annual General Meeting in 2017
AGM Information
2017-04-05 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-03-31 Danish
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-03-31 English
Det samlede antal aktier og stemmerettigheder i Zealand pr. 31. marts 2017
Regulatory Filings
2017-03-31 English
Total number of shares and voting rights in Zealand at March 31, 2017
Share Issue/Capital Change
2017-03-31 English
Director's Dealing 2017
Director's Dealing
2017-03-27 English
Director's Dealing 2017
Director's Dealing
2017-03-27 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-03-23 Danish
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-03-23 English
Share Issue/Capital Change 2017
Share Issue/Capital Change
2017-03-23 English
Zealand forhøjer aktiekapitalen som følge af udnyttelse af medarbejderwarrants
Share Issue/Capital Change
2017-03-23 English
Zealand forhøjer aktiekapitalen som følge af udnyttelse af medarbejderwarrants
Share Issue/Capital Change
2017-03-23 Danish
Zealand increases its share capital as a consequence of exercise of employee warrants
Share Issue/Capital Change
2017-03-23 English
Director's Dealing 2017
Director's Dealing
2017-03-22 English
Director's Dealing 2017
Director's Dealing
2017-03-22 English
Director's Dealing 2017
Director's Dealing
2017-03-22 English
Report Publication Announcement 2017
Report Publication Announcement
2017-03-15 Danish
Report Publication Announcement 2017
Report Publication Announcement
2017-03-15 English
Zealand præsenterer helårsresultater på niveau med forventningerne og offentliggør sin årsrapport for 2016
Report Publication Announcement
2017-03-15 English
Zealand announces full-year results in line with guidance and releases its Annual Report for 2016
Annual Report FY 2016
2017-03-15 English
Zealand announces full-year results in line with guidance and releases its Annual Report for 2016
Report Publication Announcement
2017-03-15 English
Zealand Pharma convenes its Annual General Meeting 2017
Proxy Solicitation & Information Statement
2017-03-14 English
Zealand Pharma convenes its Annual General Meeting 2017
AGM Information
2017-03-14 English
Zealand indkalder til ordinær generalforsamling 2017
Proxy Solicitation & Information Statement
2017-03-14 English
Zealand indkalder til ordinær generalforsamling 2017
AGM Information
2017-03-14 Danish
Earnings Release 2016
Earnings Release Q4 2016
2017-02-08 English
Earnings Release 2016
Earnings Release Q4 2016
2017-02-08 Danish
Zealand reports Q4 2016 Lyxumia® royalty revenue
Earnings Release Q4 2016
2017-02-08 English
Zealand reports Q4 2016 Lyxumia® royalty revenue
Earnings Release Q4 2016
2017-02-08 English
Regulatory Filings 2017
Regulatory Filings
2017-01-17 Danish
Earnings Release 2017
Earnings Release Q1 2017
2017-01-17 English
Regulatory Filings 2017
Regulatory Filings
2017-01-17 English
Suliqua(TM) EU godkendelse udløser milepælsbetaling på 10 mio. USD til Zealand
Regulatory Filings
2017-01-17 English
Suliqua(TM) EU godkendelse udløser milepælsbetaling på 10 mio. USD til Zealand
Regulatory Filings
2017-01-17 Danish
EU approval of Suliqua(TM) triggers USD 10 million milestone payment to Zealand
Regulatory Filings
2017-01-17 English
Regulatory Filings 2017
Regulatory Filings
2017-01-04 Danish
Regulatory Filings 2017
Regulatory Filings
2017-01-04 English
Regulatory Filings 2017
Regulatory Filings
2017-01-04 English
Zealand reports that Sanofi announces Soliqua(TM) 100/33 now available in the U.S
Regulatory Filings
2017-01-04 English